In addition, PTTG1 could also be a potential target in tumor therapy for various types of cancer, such as melanoma, breast cancer, and ovarian cancer (Nakachi et al., 2016; Caporali et al., 2017; Meng et al., 2020). This evidence concerns the gene PTTG1 and neoplasm.